Safety Net A Drug Giant Whose Dividend Safety Isn’t as Bad as It Looks Wednesday, October 10, 2018 Pfizer’s struggles with free cash flow and dividend cuts may have a silver lining if its growth meets expectations. 1 Facebook Twitter Google + Pinterest